Search Site

Prostate Trials


Name: A Phase 3, Randomized, Efficacy and Safety Study of Enzalutamide Plus Leuprolide, Enzalutamide Monotherapy, and Placebo Plus Leuprolide in Men With High-Risk Nonmetastatic Prostate Cancer Progressing After Definitive Therapy

Description: An international, phase 3, randomized study to evaluate the efficacy and safety of enzalutamide plus leuprolide, enzalutamide monotherapy, and placebo plus leuprolide in approximately 1860 men with high-risk nonmetastatic prostate cancer progressing after radical prostatectomy or radiotherapy or both.

Status: open for recruitment

Contact Info: 212-305-6408